Battelle Ventures GP Warren joins Springboard Enterprises Life Science Council

Tracy Warren, a general partner at Battelle Ventures, has been named to the Springboard Enterprises Life Science Council, whose members work as advisors to the women-led companies in the venture catalyst’s accelerator pipeline. Warren has co-founded a number of life science companies, including BioNano Genomics, Endovalve and NellOne Therapeutics, among others.

Press Release

Battelle Ventures General Partner Tracy Warren has been named to the Springboard Enterprises Life Science Council, a global network of experts who serve as advisors to the women-led companies in the venture catalyst’s accelerator pipeline.

Warren, who has worked closely with technology transfer and economic development organizations in medical centers, universities and laboratories around the country, has co-founded a number of life-science companies, including:

• BioNano Genomics (genetic analysis), for which she is board chairman;

• Endovalve (cardiovascular devices), which merged with Micro Interventional Devices, where she serves as board member;

• NellOne Therapeutics (soft-tissue regenerative medicine), for which she is CEO; and

• NuPathe (CNS specialty pharmaceutical), which completed its IPO in 2010 and is to be acquired by Endo Health Solutions.

Having started in venture capital more than a decade ago, Warren also serves as an adviser to PDX Pharmaceuticals, which seeks a treatment for hyperphosphatemia. She is a member of the National Association of Corporate Directors, and is, in the nonprofit area, a Clemson University Research Foundation board member.

“We are fortunate to have Tracy as one of our key industry advisors,” said Amy Millman, President Springboard Enterprises.

“She has been an invaluable resource for both our organization and the leaders of such innovative and promising companies as Talk Session, TrueMotion Spine, and Life Cycle Laboratories,” Millman continued. “We appreciate her involvement, and naming her as a trusted member of our Life Science Council makes her relationship to Springboard official.”

About Battelle Ventures

Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a combined $255 million under management for creating and accelerating the development of early-stage technology companies with breakthrough solutions to key marketplace problems. The funds have enjoyed close relationships with the technology transfer offices of the National Laboratories that Battelle Ventures’ sole limited partner, Battelle Memorial Institute (Battelle), manages or co-manages for the U.S. Department of Energy. They also have similar associations with a number of university technology transfer and commercialization departments. For more information, please visit

About Springboard Enterprises

Venture-catalyst Springboard Enterprises is the premier platform for influencers, investors and innovators to meet to help women build “big businesses starting small.” Springboard sources, coaches, showcases and supports women-led growth companies seeking equity capital for product development and expansion. More than 500 women-led companies have participated in Springboard’s accelerator programs; raising more than $6 billion, creating tens of thousands of new jobs, and generating billions of dollars in annual revenue. More than 80 percent of Springboard companies are in business as independent or merged entities (including 10 that had IPOs), and many are the technology engines of publicly traded companies. For more information, please visit

Note: Battelle Ventures and Innovation Valley Partners are registered trademarks of BVP Partners, LLC. The names of other organizations, companies, products or services mentioned herein may be the trademarks of their respective owners.